tiprankstipranks
Genscript Biotech (HK:1548)
:1548
Hong Kong Market
1548
Genscript Biotech
RESEARCH TOOLSreports
Want to see HK:1548 full AI Analyst Report?

Genscript Biotech (1548) Income Statement

10 Followers

Genscript Biotech Income Statement

Last quarter (Q4 2025), Genscript Biotech's total revenue was $440.75M, a decrease of -1.67% from the same quarter last year. In Q4, Genscript Biotech's net income was $-507.37M. See Genscript Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 959.53M$ 594.49M$ 839.53M$ 625.70M$ 490.10M
Gross Profit
$ 553.20M$ 272.13M$ 270.63M$ 304.08M$ 282.52M
Operating Expenses
$ 297.96M$ 262.84M$ 244.44M$ 742.06M$ 661.81M
Depreciation and Amortization
$ 62.36M$ 61.15M$ 74.05M$ 49.08M$ 37.72M
EBITDA
$ 317.61M$ 70.43M$ -249.42M$ -389.04M$ -477.27M
Operating Income
$ 255.25M$ 9.28M$ 26.19M$ -438.11M$ -379.29M
Other Income/Expenses
$ -725.78M$ -180.08M$ 142.69M$ 6.29M$ -138.07M
Pretax Income
$ -470.53M$ -170.80M$ -350.98M$ -431.69M$ -517.36M
Net Income
$ -532.83M$ 2.96B$ -95.48M$ -226.85M$ -358.71M
Per Share Metrics
Basic EPS
$ -0.25$ -0.03$ -0.05$ -0.11$ -0.18
Diluted EPS
$ -0.25$ -0.03$ -0.05$ -0.11$ -0.18
Weighted Average Shares Outstanding
 2.17B 2.18B 2.11B 2.10B 2.03B
Weighted Average Shares Outstanding (Diluted)
 2.19B 2.18B 2.11B 2.10B 2.03B
Currency in USD

Genscript Biotech Earnings and Revenue History